• 1. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers

Professional Introduction to (S)-4-(Oxiran-2-ylmethoxy)benzonitrile (CAS No. 70987-80-3)

(S)-4-(Oxiran-2-ylmethoxy)benzonitrile, with the CAS number 70987-80-3, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of oxirane-containing benzonitrile derivatives, which are known for their versatile applications in drug development and synthetic chemistry. The enantiomeric purity of this compound, specifically the (S)-configuration, makes it a valuable intermediate in the synthesis of chiral drugs, which are increasingly important in modern medicine due to their enhanced specificity and reduced side effects.

The structure of (S)-4-(Oxiran-2-ylmethoxy)benzonitrile consists of a benzonitrile core substituted with an oxiran-2-ylmethoxy group. This unique structural feature imparts distinct chemical properties that make it a promising candidate for various biochemical applications. The oxirane ring, also known as an epoxide, is a highly reactive moiety that can undergo ring-opening reactions with nucleophiles, making it useful in the synthesis of more complex molecules. The benzonitrile moiety, on the other hand, contributes to the compound's solubility in polar organic solvents and its ability to participate in hydrogen bonding interactions, which are crucial for molecular recognition processes.

In recent years, there has been a surge in research focused on the development of novel chiral auxiliaries and ligands for asymmetric synthesis. (S)-4-(Oxiran-2-ylmethoxy)benzonitrile has been explored as a potential chiral building block in the synthesis of non-proteinogenic amino acids and other chiral molecules. Its utility in constructing enantiomerically pure compounds has been demonstrated in several studies, where it has been used to synthesize advanced intermediates for antiviral and anticancer agents. The reactivity of the oxirane ring allows for selective functionalization, enabling chemists to tailor the molecular structure with precision.

The pharmaceutical industry has shown particular interest in this compound due to its potential applications in the development of small-molecule drugs. For instance, researchers have investigated its use as a precursor in the synthesis of protease inhibitors, which are critical for treating diseases such as HIV and hepatitis C. The benzonitrile group provides a site for further derivatization, allowing for the introduction of additional pharmacophores that can enhance drug potency and selectivity. Additionally, the (S)-configuration ensures that any resulting drug candidates will retain high enantiomeric purity, which is often a prerequisite for clinical approval.

Recent advancements in computational chemistry have also highlighted the importance of (S)-4-(Oxiran-2-ylmethoxy)benzonitrile in drug design. Molecular modeling studies have shown that this compound can interact with biological targets in specific ways due to its unique structural features. These insights have guided the development of novel therapeutic strategies aimed at improving drug efficacy and reducing toxicity. The oxirane ring's ability to form stable complexes with biological molecules makes it an attractive scaffold for designing targeted therapeutics.

The synthetic pathways for preparing (S)-4-(Oxiran-2-ylmethoxy)benzonitrile have been optimized to ensure high yields and enantiomeric purity. One common approach involves the reaction of benzonitrile derivatives with epoxides under controlled conditions. Catalytic methods have been particularly effective in achieving high selectivity and minimizing side reactions. These synthetic techniques are essential for producing sufficient quantities of the compound for both research and industrial applications.

The safety profile of (S)-4-(Oxiran-2-ylmethoxy)benzonitrile is another critical consideration in its application within pharmaceutical research. While not classified as a hazardous material under standard regulatory guidelines, proper handling procedures must be followed to ensure worker safety. This includes using appropriate personal protective equipment (PPE) and working in well-ventilated areas to minimize exposure risks. Detailed safety data sheets (SDS) are available for researchers who require additional information on handling and storage recommendations.

The future prospects of this compound are promising, with ongoing research exploring new applications in drug discovery and materials science. The ability to functionalize both the oxirane ring and the benzonitrile group provides a rich platform for innovation. As our understanding of molecular interactions continues to grow, compounds like (S)-4-(Oxiran-2-ylmethoxy)benzonitrile will undoubtedly play a pivotal role in shaping the next generation of therapeutic agents.

• 93744-17-3(Benzonitrile,2-[(2R)-2-oxiranylmethoxy]-)
• 159183-52-5(Benzonitrile,3-[(2S)-2-oxiranylmethoxy]-)
• 38465-16-6(2-(2-Oxiranylmethoxy)benzonitrile)
• 38791-92-3(4-(2-Oxiranylmethoxy)benzenecarbonitrile)
• 70987-79-0((r)-4-(oxiran-2-ylmethoxy)benzonitrile)
• 904734-43-6((S)-2-(OXIRAN-2-YLMETHOXY)BENZONITRILE)
• 917895-14-8(Benzonitrile, 4,4'-[(2-hydroxy-1,3-propanediyl)bis(oxy)]bis-)
• 18859-06-8( )
• 7476-06-4(4,4'-(1,3-Propanediylbisoxy)bisbenzonitrile)
• 60758-84-1(4-propoxybenzonitrile)